Form 4: NeuroOne Medical Technologies Officer Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies, disposed of 252 shares of common stock on April 30, 2024, to satisfy tax obligations.
Summary
- On April 30, 2024, Steve Mertens, the Chief Technology Officer of NeuroOne Medical Technologies Corp, disposed of 252 shares of common stock.
- The transaction was executed to cover tax obligations related to equity compensation.
- The shares were disposed of at a price of $1.13 per share.
- Following the transaction, Mertens directly owns 176,409 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine disposal of shares to cover tax obligations, which is a common practice.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors to gauge management's sentiment and confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 04/30/2024 | Date of stock disposal transaction |
| 05/02/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.